Posts Tagged ‘therapeutics’
Sanofi Ventures leads $17M investment in Click Therapeutics, finalist @ 2017 Brainnovations Pitch Contest
Sanofi Backs Click Therapeutics as Digital Medicines Gain Momentum (Xconomy): “Drug makers are making more bets on the nascent field of digital medicine. The latest example: Click Therapeutics announced Monday that it grabbed a $17 million investment led by Sanofi Ventures, the Cambridge, MA-based venture capital arm of the French pharmaceutical giant.
Read MoreThree pioneers of neuroplasticity research discuss the present and future of rewiring the brain
A DISCUSSION WITH EVE MARDER, MICHAEL MERZENICH AND CARLA SHATZ (2016 KAVLI PRIZE IN NEUROSCIENCE): “Our view of the brain as something constantly shaped by thought and experience is only a few decades old, yet it has profoundly influenced how we teach and treat, raise our young and care for the old. Eve Marder, Michael Merzenich and…
Read MoreAkili raises an additional $11.9M; brings Amgen, Merck, Pfizer and Shire to the digital medicine table
—– Akili Adds Amgen Ventures and M Ventures* to Series B Financing, Increasing Round to $42.4 Million (press release): “Akili Interactive Labs, Inc. (“Akili”), a digital medicine company developing novel, non-pharmacological therapeutics and diagnostics for cognitive disorders, today announced an $11.9 million expansion of its recent Series B financing.
Read MoreBrain Damage, Therapeutics and the Blood-Brain Barrier
Blood-Brain Barrier Less Permeable in Newborns than Adults after Acute Stroke (press release): “The blood-brain barrier is selectively permeable and blocks unwanted molecules from entering into the brain. The selectivity is achieved
Read More